Trial Profile
A Randomized, Open-Label, Active-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Ferumoxytol Compared With Oral Iron for the Treatment of Iron Deficiency Anemia in Pediatric Subjects With Nondialysis-dependent Chronic Kidney Disease
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary) ; Ferrous sulfate
- Indications Iron deficiency anaemia
- Focus Adverse reactions; Pharmacokinetics; Registrational; Therapeutic Use
- Sponsors AMAG Pharmaceuticals
- 15 Sep 2014 New trial record